Clinical Trial Update: A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating romiplostim as a first-line treatment for newly diagnosed adults with Primary Immune Thrombocytopenia. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Romiplostim (romiplostim)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Primary Immune Thrombocytopenia | Phase 2 | Status: RECRUITING